Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000517328 | SCV000616024 | uncertain significance | not provided | 2018-06-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000525218 | SCV000642804 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2022-07-19 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with serine, which is neutral and polar, at codon 7262 of the TTN protein (p.Thr7262Ser). This variant is present in population databases (rs200954184, gnomAD 0.01%). This missense change has been observed in individual(s) with sick sinus syndrome (PMID: 27182706). ClinVar contains an entry for this variant (Variation ID: 448774). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This variant is located in the I band of TTN (PMID: 25589632). Variants in this region may be clinically relevant, but have not been definitively shown to cause cardiomyopathy or neuromuscular disease (PMID: 27493940, 32778822). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV000517328 | SCV001770756 | likely benign | not provided | 2019-01-10 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27182706) |
Revvity Omics, |
RCV000517328 | SCV003824174 | uncertain significance | not provided | 2019-06-27 | criteria provided, single submitter | clinical testing |